{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:00:40Z","timestamp":1790308840972,"version":"4.1.0"},"reference-count":52,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Disability and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2042605"],"award-info":[{"award-number":["2042605"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The harm potential of gabapentinoids is well established, with concerns about non\u2010medical use increasing alongside prescribing rates. However, less is known about the characteristics of people who use gabapentinoids obtained through non\u2010prescribed routes. This study explored demographic and behavioural factors associated with gabapentinoid use, including differences between prescribed and non\u2010prescribed sources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Data from the Global Drug Survey 2021 (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200924,954). Multivariable logistic regression models identified correlates of: (i) past\u2010year use; (ii) prescribed versus non\u2010prescribed acquisition; and (iii) using gabapentinoids prescribed to others versus prescribed to oneself.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Past\u2010year gabapentinoid use was reported by 2.9% of respondents. In adjusted models, past\u2010year use was associated with being a man, reporting a mental health or neurodevelopmental condition, use of benzodiazepines, opioids and illicit\u00a0drugs. Among respondents who had ever used gabapentinoids (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091112), 45.6% reported using their own prescription,\u00a027.2% used a non\u2010prescribed source and 27.2% used medication prescribed to someone else. Non\u2010prescribed use (i.e.,\u00a0not\u00a0from a personal prescription) was more common among younger respondents, cis men and those reporting illicit drug or benzodiazepine use. Respondents with mental health or neurodevelopmental conditions were more likely to report prescribed use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and Conclusions<\/jats:title>\n                    <jats:p>A substantial proportion of gabapentinoid use occurs outside formal prescribing pathways, including use of medications prescribed to others. Non\u2010prescribed use is embedded within broader substance use behaviours, highlighting specific demographic groups with higher odds of nonprescribed use. These findings underscore the importance of targeted harm\u2010reduction responses and continued attention to diversion\u2010prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dar.70248","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:21:19Z","timestamp":1789021279000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non\u2010Prescribed Gabapentinoid Use: Demographic and Behavioural Risk Profiles in a Large International Sample"],"prefix":"10.1111","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-0902","authenticated-orcid":false,"given":"Jennifer","family":"Seddon","sequence":"first","affiliation":[{"name":"Centre for Psychological Research Oxford Brookes University  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-9379","authenticated-orcid":false,"given":"Monica J.","family":"Barratt","sequence":"additional","affiliation":[{"name":"National Drug Research Institute and enAble Institute Curtin University  Perth Australia"},{"name":"Harm and Risk Reduction Program Burnet Institute  Melbourne Australia"},{"name":"National Drug and Alcohol Research Centre UNSW Sydney  Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-9772","authenticated-orcid":false,"given":"Cheneal","family":"Puljevi\u0107","sequence":"additional","affiliation":[{"name":"School of Public Health The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7474-0173","authenticated-orcid":false,"given":"Jason A.","family":"Ferris","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research The University of Queensland  Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-8015","authenticated-orcid":false,"given":"Adam R.","family":"Winstock","sequence":"additional","affiliation":[{"name":"University College London  London UK"},{"name":"Global Drug Survey  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3577-3276","authenticated-orcid":false,"given":"Emma L.","family":"Davies","sequence":"additional","affiliation":[{"name":"Centre for Psychological Research Oxford Brookes University  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.14412"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0700-x"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13324"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12358"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.5268"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100579"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.7856"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101120"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40637-8"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1704633"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2022.12.001"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13892"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1578-5"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0164-4"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01432-7"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01217-8"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12277"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2020.1799943"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.016"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13843"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2021.2024709"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2018.06.018"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00985-6"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2096"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/injuryprev-2016-042308"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2014.04.028"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-017-0467-3"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12159"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-101868"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1464-6"},{"issue":"10","key":"e_1_2_11_32_1","first-page":"605","article-title":"Potential for Pregabalin Abuse or Diversion After Past Drug\u2010Seeking Behavior","volume":"110","author":"Filipetto F. A.","year":"2010","journal-title":"Journal of Osteopathic Medicine"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090313"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2147"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107741"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15352"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.01.018"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2020.05.017"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2017.08.430"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkz036"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3200\/JACH.54.5.269-278"},{"key":"e_1_2_11_42_1","volume-title":"Monitoring Drug Use in the Digital Age: Studies in Web Surveys: Using the Global Drug Survey for Harm Reduction","author":"Winstock A. R.","year":"2022"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178221817716391"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"e_1_2_11_45_1","volume-title":"The Alcohol Use Disorders Identification Test; Guidelines for Use in Primary Care","author":"Babor T.","year":"2001"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1037\/bul0000102"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.027"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01064-5"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000003056"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1009950"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.105064"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.70165"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.104929"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70248","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dar.70248","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.70248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:28:34Z","timestamp":1790306914000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.70248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/dar.70248"],"URL":"https:\/\/doi.org\/10.1111\/dar.70248","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-03-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70248"}}